Evidence map›Paper›PMID 27681389›Full record

ArticleBiology direct2016

Weighted-SAMGSR: combining significance analysis of microarray-gene set reduction algorithm with pathway topology-based weights to select relevant genes.

Suyan Tian, Howard H Chang, Chi Wang

Abstract read
In one paragraph

Article in Biology direct, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suyan TianDivision of Clinical Research, The First Hospital of Jilin University, 71Xinmin Street, Changchun, Jilin, China, 130021. stian@rockefeller.edu.
Howard H ChangDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA, 30322, USA.
Chi WangDepartment of Biostatistics, Markey Cancer Center, The University of Kentucky, 800 Rose St., Lexington, KY, 40536, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been demonstrated that a pathway-based feature selection method that incorporates biological information within pathways during the process of feature selection usually outperforms a gene-based feature selection algorithm in terms of predictive accuracy and stability. Significance analysis of microarray-gene set reduction algorithm (SAMGSR), an extension to a gene set analysis method with further reduction of the selected pathways to their respective core subsets, can be regarded as a pathway-based feature selection method.

methodsIn SAMGSR, whether a gene is selected is mainly determined by its expression difference between the phenotypes, and partially by the number of pathways to which this gene belongs. It ignores the topology information among pathways. In this study, we propose a weighted version of the SAMGSR algorithm by constructing weights based on the connectivity among genes and then combing these weights with the test statistics.

resultsUsing both simulated and real-world data, we evaluate the performance of the proposed SAMGSR extension and demonstrate that the weighted version outperforms its original version.

conclusionsTo conclude, the additional gene connectivity information does faciliatate feature selection. REVIEWERS: This article was reviewed by Drs. Limsoon Wong, Lev Klebanov, and, I. King Jordan.

Indexed as

Multiple sclerosis (MS)Non-small cell lung cancer (NSCLC)Pathway-based feature selectionPathway knowledgeSignificance analysis of microarray (SAM)Weighted gene expression profiles

Identifiers

PMID27681389
PMCPMC5041498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.